IMCD N.V.
100.45
EUR
0.00
(0.00%)
ISIN
NL0010801007
Return %
Stock
S&P 500
1Y
5.54
14.20
3Y
-9.67
81.12
5Y
-46.64
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Marcus Jordan
- Full Time Employees
- 5,246
- Sector
- Distribution services
- Industry
- Wholesale distributors
- Address
- Wilhelminaplein 32 Rotterdam ZH Netherlands 3072 DE
- IPO Date
- Jun 27, 2014
- Website
- imcdgroup.com
- Similar Companies
- Business
- IMCD N.V. is a global leader in the distribution and formulation of specialty chemicals and ingredients. Headquartered in Rotterdam, the Netherlands, and founded in 1995, the company operates in over 60 countries across Europe, the Middle East, Africa, North America, South America, and Asia-Pacific, serving industries including pharmaceuticals, beauty and personal care, food and nutrition, advanced materials, coatings and construction, home care and industrial, lubricants and energy, and industrial solutions. IMCD provides market-focused technical expertise, formulation services, and value-added solutions such as repacking, dilution, and blending through its network of 110 offices, 80 laboratories, and 150 warehouses worldwide; its core product portfolio encompasses specialty chemicals like surfactants, polymers, esters, dyes, pigments, monomers, intermediates, building blocks, processing aids, reactive diluants, solvents, additives, and surface active agents for coatings, adhesives, plastics, agrochemicals, lubricants, and fuel additives; pharmaceutical ingredients including active pharmaceutical ingredients, excipients, and intermediates; food and nutrition ingredients and additives; beauty and personal care components; and advanced materials for diverse applications in automotive, industrial, oil and gas, textiles, water treatment, and electronics. In the past two years, IMCD has pursued aggressive growth through multiple strategic acquisitions, completing six in the first nine months of 2025 alone, including TECOM Ingredients S.A. in Iberia for food and beverage enhancement, Trichem Healthcare in India to bolster pharmaceutical supply chains in India and the Middle East, Tillmanns in Italy for expanded industrial, water, and food market presence, Ferrer Alimentación in Iberia to accelerate food and beverage capabilities, Dong Yang FT in South Korea for beauty and personal care strengthening, and others such as YCAM, Daoqin, Selechimica, and prior 2024 deals like CJ Shah, Euro-Chemopharma, Biofresh, Reschem, and Guangzhou RBD Chemical, collectively adding approximately EUR 340 million in annualized revenues and 185 employees. These moves, alongside the establishment of an Innovation Lab in 2024 and over EUR 5 million in R&D investment in 2023 yielding more than 30 new eco-friendly product lines for 2025 launches, underscore IMCD's commitment to scaling operations, enhancing regional footprints, and driving innovation in sustainable solutions.
Company News
Goldman Sachs names four 'must own' European stocks for 2027
IMCD N.V. (IMCDY) Q2 2026 Earnings Call Transcript
Fiduciary Management Q1 2026: A Few Pockets Where We Are Finding Attractive Investments
IMCD N.V. (IMCDY) Q4 2025 Earnings Call Transcript
Oakmark International Strategy Q4 2025 New Investments And Divestments
IMCD: Specialty Chemical Distribution At A Special Price
IMCD (OTC:IMCDY) Trading Up 7.1% – Time to Buy?
IMCD (OTC:IMCDY) Trading Down 0.4% – What’s Next?
IMCD N.V. (IMCDY) Q3 2025 Earnings Call Transcript
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
IMCD And Azelis: Two Specialty Chemical Distributors With Massive Return Potential
IMCD price target lowered to EUR 172 from EUR 187 at Berenberg